You have 9 free searches left this month | for more free features.

Condition

Parkinson's Disease (2)

Dyskinesias (1)

Hallucinations (1)

Psychoses (1)

Schizophrenia (1)

Overall Status

Completed (3)

Sign in for free

Phase

phase 2 (3)

Sponsor

ACADIA Pharmaceuticals Inc. (2)

National Institute of Neurological Disorders and Stroke (NINDS) (1)

Collaborator

Intervention

acp-103 (3)

intravenous levodopa (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (2)

NIH (1)

Study Type

Interventional (3)

acp-103

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Parkinson's Disease, Dyskinesias Trial run by the NINDS (Intravenous Levodopa, ACP-103)

Completed

Parkinson's Disease
Dyskinesias

Intravenous Levodopa
ACP-103

Bethesda, Maryland

National Institutes of Health Clinical Center, 9000 Rockville Pi

Jun 30, 2017

Schizophrenia Trial in Brazil, United States (ACP-103)

Completed

Schizophrenia

ACP-103

Cerritos, California
+16 more

Mar 20, 2007

Hallucinations, Psychoses, Parkinson's Disease Trial in United States (ACP-103)

Completed

Hallucinations
+2 more

ACP-103

Fountain Valley, California
+12 more

Dec 5, 2005